Back to Search
MARCIO MALOGOLOWKIN, MD
MD
Pediatric Hematology & Oncology Physician
NPI: 1457451270IndividualAccepts Medicare
Specialties, Licenses & Credentials
Pediatric Hematology & Oncology PhysicianPrimary
Pediatrics — Pediatric Hematology-Oncology
Code: 2080P0207X
57273-20(WI)A49278(CA)
Education
OTHER
Class of 1982
Research & Publications (20)
Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group.
PMID 17539021·Pediatr Blood Cancer·2008
3-trial
Redefining the role of doxorubicin for the treatment of children with hepatoblastoma.
PMID 18467729·J Clin Oncol·2008
4-observational
Intensified platinum therapy is an ineffective strategy for improving outcome in pediatric patients with advanced hepatoblastoma.
PMID 16782927·J Clin Oncol·2006
2-rct
Feasibility and toxicity of chemoembolization for children with liver tumors.
PMID 10715298·J Clin Oncol·2000
3-trial
Establishment and characterization of a cancer cell line derived from an aggressive childhood liver tumor.
PMID 19637320·Pediatr Blood Cancer·2009
8-other
Predictive power of pretreatment prognostic factors in children with hepatoblastoma: a report from the Children's Oncology Group.
PMID 19588519·Pediatr Blood Cancer·2009
8-other
Surgical resection of pulmonary metastatic lesions in children with hepatoblastoma.
PMID 18082706·J Pediatr Surg·2007
8-other
The addition of ifosfamide/etoposide to cisplatin/teniposide improves the survival of children with retinoblastoma and orbital involvement.
PMID 17921851·J Pediatr Hematol Oncol·2007
4-observational
Extracranial malignant rhabdoid tumors in childhood: the Childrens Hospital Los Angeles experience.
PMID 17828773·Cancer·2007
8-other
Treatment of Wilms tumor relapsing after initial treatment with vincristine and actinomycin D: a report from the National Wilms Tumor Study Group.
PMID 16547940·Pediatr Blood Cancer·2007
4-observational
Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study.
PMID 16710034·J Clin Oncol·2006
8-other
Treatment of retinoblastoma patients with chemoreduction plus local therapy: experience of the AC Camargo Hospital, Brazil.
PMID 16794500·J Pediatr Hematol Oncol·2006
8-other
Prognostic factors in children with extragonadal malignant germ cell tumors: a pediatric intergroup study.
PMID 16735707·J Clin Oncol·2006
8-other
Post-transplant multiple myeloma in a pediatric renal transplant patient.
PMID 16086426·Pediatr Blood Cancer·2006
5-case
Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group.
PMID 16129848·J Clin Oncol·2005
3-trial
Amifostine does not protect against the ototoxicity of high-dose cisplatin combined with etoposide and bleomycin in pediatric germ-cell tumors: a Children's Oncology Group study.
PMID 15999362·Cancer·2005
8-other
Predictors of outcome in children with Langerhans cell histiocytosis.
PMID 15768381·Pediatr Blood Cancer·2005
8-other
Management of Wilms' tumour: current practice and future goals.
PMID 14700607·Lancet Oncol·2004
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 9000 W WISCONSIN AVE
MILWAUKEE, WI 53226 - Phone
- (414) 955-4170
Quick Facts
- NPI
- 1457451270
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 44
- Publications
- 20
Are you this provider?
Claim Your Profile